These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25112726)

  • 1. DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.
    Esposito MT; So CW
    Chromosoma; 2014 Dec; 123(6):545-61. PubMed ID: 25112726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of DNA Repair Pathways in AML Chemosensitivity.
    Pearsall EA; Lincz LF; Skelding KA
    Curr Drug Targets; 2018; 19(10):1205-1219. PubMed ID: 29318968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are DNA damage response kinases a target for the differentiation treatment of acute myeloid leukemia?
    Pennisi R; Albanesi J; Ascenzi P; Nervi C; di Masi A
    IUBMB Life; 2018 Nov; 70(11):1057-1066. PubMed ID: 30296357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
    Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
    Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer.
    Wu Z; Li S; Tang X; Wang Y; Guo W; Cao G; Chen K; Zhang M; Guan M; Yang D
    Theranostics; 2020; 10(9):3939-3951. PubMed ID: 32226530
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias.
    Popp HD; Naumann N; Brendel S; Henzler T; Weiss C; Hofmann WK; Fabarius A
    Leuk Res; 2017 Jun; 57():112-118. PubMed ID: 28359030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
    Hubner SE; de Camargo Magalhães ES; Hoff FW; Brown BD; Qiu Y; Horton TM; Kornblau SM
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between OGG1 S326C CC genotype and elevated relapse risk in acute myeloid leukemia.
    Gotoh N; Saitoh T; Takahashi N; Kasamatsu T; Minato Y; Lobna A; Oda T; Hoshino T; Sakura T; Shimizu H; Takizawa M; Handa H; Yokohama A; Tsukamoto N; Murakami H
    Int J Hematol; 2018 Sep; 108(3):246-253. PubMed ID: 29737460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc Prevents DNA Damage in Normal Cells but Shows Genotoxic and Cytotoxic Effects in Acute Myeloid Leukemia Cells.
    Costa MI; Lapa BS; Jorge J; Alves R; Carreira IM; Sarmento-Ribeiro AB; Gonçalves AC
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
    Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
    J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immune and DDR pathway classifier: A novel pathway-based classification aimed at tailoring personalized therapies for acute myeloid leukemia patients.
    Huang Y; Zhang Y; Zhou Q; Teng Y; Sui M; Zhang F
    Comput Biol Med; 2023 Aug; 162():107093. PubMed ID: 37269679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia.
    Seedhouse C; Faulkner R; Ashraf N; Das-Gupta E; Russell N
    Clin Cancer Res; 2004 Apr; 10(8):2675-80. PubMed ID: 15102670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of spongean alkaloids on mechanisms of cell death, cell cycle progression and DNA damage response (DDR) of acute myeloid leukemia (AML) cells.
    Stuhldreier F; Kassel S; Schumacher L; Wesselborg S; Proksch P; Fritz G
    Cancer Lett; 2015 May; 361(1):39-48. PubMed ID: 25697484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2‑deficient human acute myeloid leukemia.
    Xu Y; Lin Y; Luo Y; Yang Y; Long B; Fang Z; Liu L; Zhang J; Zhang X
    Oncol Rep; 2020 Oct; 44(4):1455-1466. PubMed ID: 32945515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy.
    Xu R; Yu S; Zhu D; Huang X; Xu Y; Lao Y; Tian Y; Zhang J; Tang Z; Zhang Z; Yi J; Zhu HH; Zheng X
    Nat Commun; 2019 Aug; 10(1):3812. PubMed ID: 31444354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage response inhibitors: An avenue for TNBC treatment.
    Jin J; Tao Z; Cao J; Li T; Hu X
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188521. PubMed ID: 33556453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance.
    Staudt D; Murray HC; McLachlan T; Alvaro F; Enjeti AK; Verrills NM; Dun MD
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
    Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
    Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.